• 1 January 1977
    • journal article
    • research article
    • Vol. 37  (7) , 2306-2308
Abstract
The distribution of 5-[18F]fluorouracil was compared in 2 variants of the same tumor in C57BL .times. DBA/2 F1 mice: solid L1210 lymphocytic leukemia tumor susceptible to 5-fluorouracil treatment and the same tumor, made resistant to the drug over a 34 generation span. Significant differences in 5-[18F]fluorouracil distribution were observed, most notably in the tumor:blood ratios at 12 h postinjection. The drug responsive tumor showed a 20:1 concentration ratio, whereas the drug resistant tumor only had a 4:1 concentration ratio. These differences may be a reflection of similar ratio differences in humans. This technique may allow, by noninvasive quantification of tumor:blood ratios following administration of 5-[18F]-fluorouracil to man, the differentiation of those human tumors that are likely to respond to drug therapy from those in which the response will be minimal or nil.

This publication has 0 references indexed in Scilit: